The design and synthesis of novel matrix metalloproteinase inhibitors
The design and synthesis of novel matrix metalloproteinase inhibitors
Matrix meetalloproteinases (MMPs) are a therapeutic target for many pharmaceutical companies as they are involved in numerous disease areas such as tumour metastasis, rheumatoid arthritis, multiple sclerosis and coronary heart disease.
Recently, the ancorinoside natural products were described as micromolar MMP inhibitors. Chapter one describes the synthesis of an array of tetramic acids, the core functional group present in the ancorinosides. The compounds synthesised were then tested in biological assays in order to determine whether any were effective MMP inhibitors. The use of molecular modelling technology in aiding the synthesis of tetramic acids is discussed. In chapter two, keto-pyrrolidinones are introduced as an alternative scaffold to tetramic acids. A series of keto-pyrrolidinones was prepared and tested for MMP activity.
The third chapter of my thesis describes synthetic studies directed towards ageladine A, a recently isolated MMP inhibitor. The synthesis of the structure reported for ageladine A was achieved via a Suzuki coupling of the pyrrole and pyridine portions. Analogues of this have been tested for MMP activity.
University of Southampton
Franks, Helen Clare
930160c2-7404-41d4-bca8-78735c92362b
2005
Franks, Helen Clare
930160c2-7404-41d4-bca8-78735c92362b
Franks, Helen Clare
(2005)
The design and synthesis of novel matrix metalloproteinase inhibitors.
University of Southampton, Doctoral Thesis.
Record type:
Thesis
(Doctoral)
Abstract
Matrix meetalloproteinases (MMPs) are a therapeutic target for many pharmaceutical companies as they are involved in numerous disease areas such as tumour metastasis, rheumatoid arthritis, multiple sclerosis and coronary heart disease.
Recently, the ancorinoside natural products were described as micromolar MMP inhibitors. Chapter one describes the synthesis of an array of tetramic acids, the core functional group present in the ancorinosides. The compounds synthesised were then tested in biological assays in order to determine whether any were effective MMP inhibitors. The use of molecular modelling technology in aiding the synthesis of tetramic acids is discussed. In chapter two, keto-pyrrolidinones are introduced as an alternative scaffold to tetramic acids. A series of keto-pyrrolidinones was prepared and tested for MMP activity.
The third chapter of my thesis describes synthetic studies directed towards ageladine A, a recently isolated MMP inhibitor. The synthesis of the structure reported for ageladine A was achieved via a Suzuki coupling of the pyrrole and pyridine portions. Analogues of this have been tested for MMP activity.
Text
991600.pdf
- Version of Record
More information
Published date: 2005
Identifiers
Local EPrints ID: 465746
URI: http://eprints.soton.ac.uk/id/eprint/465746
PURE UUID: 70fd8a3f-4bf4-4ea7-bd71-1120d9297e4f
Catalogue record
Date deposited: 05 Jul 2022 02:51
Last modified: 16 Mar 2024 20:21
Export record
Contributors
Author:
Helen Clare Franks
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics